These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 4167195)

  • 1. [Action of antithyroid drugs on the thyroid gland blood vessels in Basedow's disease].
    Yamasaki T
    Yonago Acta Med; 1966 Jul; 10(2):69-73. PubMed ID: 4167195
    [No Abstract]   [Full Text] [Related]  

  • 2. The challenge of treating Graves'-Basedow's disease patients with antithyroid drugs (ATD) in a large university hospital.
    Iacona A; Lima N; Perozim LM; Knobel M; Cavaliere H; Medeiros-Neto G
    Exp Clin Endocrinol; 1991 May; 97(2-3):297-302. PubMed ID: 1717299
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hyperthyreosis in Basedow's disease].
    Välimäki MJ
    Duodecim; 1998; 114(5):447-54. PubMed ID: 11466937
    [No Abstract]   [Full Text] [Related]  

  • 4. The evolution of the ophthalmopathy during antithyroid drug therapy and its relationship with serum thyroglobulin and antithyroglobulin antibody in patients with Basedow's disease.
    Bromberg N; Werner RS; Sgarbi JA; Werner MC; Romaldini JH
    Exp Clin Endocrinol; 1991 May; 97(2-3):354-7. PubMed ID: 1717300
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evolution of thyroximemia in the course of Basedow's disease treated with thyroid antagonists].
    Linquette M; Fossati P; Decoulx M; Racadot A; Benoit G; Asfour M
    Lille Med; 1977 Oct; 22(8):489-94. PubMed ID: 73116
    [No Abstract]   [Full Text] [Related]  

  • 6. [L.A.T.S. activity during hyperthyroidism. Apropos of 143 cases of Basedow's disease].
    Letonturier P; Tourneur R; Sénécal P
    Ann Med Interne (Paris); 1974 May; 125(5):463-7. PubMed ID: 4140703
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of Tc 99m-pertechnetate for the study inorganic iodine absorption by the thyroid gland under the effects of antithyroid preparations].
    Kotliarov EV; Budkevich IuB
    Med Radiol (Mosk); 1970 Jun; 15(6):55-8. PubMed ID: 4194224
    [No Abstract]   [Full Text] [Related]  

  • 8. [Thyroid hormone dynamics during the thyrostatic treatment of Basedow's disease].
    Vŭrbanov V; Zakharieva B; Manolov D; Zhelev N
    Vutr Boles; 1990; 29(1):68-73. PubMed ID: 1697716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of antithyroid treatment on the pituitary thyrotropin reserve in patients with Basedow's disease].
    Gianrossi R; Murialdo G; Gallamini A; Rolandi E
    Boll Soc Ital Biol Sper; 1976 Dec; 52(24):2082-7. PubMed ID: 71904
    [No Abstract]   [Full Text] [Related]  

  • 10. [Basedow's disease in the pregnant woman. Should thyroxine be added to synthetic antithyroid drugs?].
    Lutz P
    Nouv Presse Med; 1976 Oct; 5(32):2081. PubMed ID: 62341
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of Basedow's disease in pregnancy with antithyroid drugs].
    Iino S; Iigatani K; Ban Y; Miyamoto M; Watanabe M
    Horumon To Rinsho; 1974 Feb; 22(2):251-62. PubMed ID: 4136016
    [No Abstract]   [Full Text] [Related]  

  • 12. [Dynamic thyroid hormone levels during the thyrostatic treatment of Basedow's disease].
    Vŭrbanov V; Zakharieva B; Manolov D
    Vutr Boles; 1988; 27(4):15-8. PubMed ID: 2463711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug therapy of Basedow's disease].
    Ishii J
    Nihon Naika Gakkai Zasshi; 1990 Jul; 79(7):868-72. PubMed ID: 1700042
    [No Abstract]   [Full Text] [Related]  

  • 14. [Proceedings: Recovery rate in Basedow's disease treated with thyroid antagonists: frequency of development of suppression 1 year after the initiation of the treatment].
    Nagataki S; Uchimura H; Ikeda H; Matsuzaki F; Imai Y
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):424. PubMed ID: 4141673
    [No Abstract]   [Full Text] [Related]  

  • 15. [Combination of low doses of 131-iodine and synthetic antithyroid agents for prolonged treatment in Basedow's disease. Apropos of 165 cases].
    Mitouze J; Jaffiol C; Baldet L; Ghachem M
    Rev Fr Endocrinol Clin; 1972; 13(4):339-61. PubMed ID: 4122472
    [No Abstract]   [Full Text] [Related]  

  • 16. [Basedow's disease. 1. Drug therapy of hyperthyroidism].
    Tourniaire J
    Lyon Med; 1971; 18():Suppl:48-51. PubMed ID: 4105819
    [No Abstract]   [Full Text] [Related]  

  • 17. [Basedow's disease].
    Kumahara Y
    Naika; 1965 Aug; 16(2):332-4. PubMed ID: 4161079
    [No Abstract]   [Full Text] [Related]  

  • 18. [The pharmacological therapy of Basedow's disease].
    Lazzarin M; Segattini L; Benati F
    Recenti Prog Med; 1993 Oct; 84(10):698-708. PubMed ID: 7694335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surgical treatment of Basedow's disease. Review of a series of 823 operations (author's transl)].
    Blondeau P; Wolfeler L; Rene L
    Ann Chir; 1978 Dec; 32(10):779-87. PubMed ID: 86322
    [No Abstract]   [Full Text] [Related]  

  • 20. Responsiveness to thyrotropin releasing hormone and thyroid suppressibility in Graves' disease patients remaining in remission after antithyroid drug therapy.
    Rajatanavin R; Mahatumarat P; Poochanugool L; Kumpolpunth S; Himathongkam T
    J Med Assoc Thai; 1981 Jan; 64(1):11-8. PubMed ID: 6163837
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.